Jay Cooper
MD
Professor Emeritus of Radiation Oncology
👥Biography 个人简介
Jay Cooper led the RTOG 9501 trial establishing postoperative concurrent chemoradiation for high-risk head and neck cancer, a landmark in adjuvant HNSCC treatment. This trial defined the role of adjuvant cisplatin-based chemoradiation based on pathologic risk factors. His work remains a cornerstone of HNSCC surgical management guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jay Cooper 的研究动态
Follow Jay Cooper's research updates
留下邮箱，当我们发布与 Jay Cooper（Maimonides Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment